Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Providing an energy boost
What the Clinical Evidence Shows While large-scale randomized controlled trials specifically measuring testosterone as a primary endpoint in tirzepatide users are still emerging, the available evidence is encouraging: The SURMOUNT trials demonstrated average weight losses of 15-22.5% of body weight, a degree of fat reduction strongly associated with testosterone recovery in men with obesity-related hypogonadism (Jastreboff et al., 2022, NEJM )
But why now
Multi-dose vials, once accessed with a needle, have additional storage considerations related to sterility maintenance
By subscribing, you agree to our Terms of Service and Privacy Policy
Semaglutide has been associated with modest increases in heart rate in some patients, warranting cardiovascular monitoring in susceptible individuals
US$ 29.33
US$ 28.17
US$ 21.52
